Cargando…
The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice
PURPOSE OF REVIEW: The launch of new effective and safe cardiovascular drugs has produced large gains in health outcomes for several cardiovascular conditions. But this innovation comes at the cost of rapidly increasing pharmaceutical spending and high out-of-pocket costs. RECENT FINDINGS: In the US...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486158/ https://www.ncbi.nlm.nih.gov/pubmed/34599393 http://dx.doi.org/10.1007/s11886-021-01598-w |